PI Industries Limited has submitted to the Exchange, the Unaudited Standalone & Consolidated Financial Results for the quarter ended Jun 30, 2025.
PIIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
PI Industries reported its Q1 FY26 results with standalone revenue from operations at ₹17,691 Mn, down about 12% from ₹20,120 Mn in the same quarter last year. Standalone profit after tax was ₹4,643 Mn versus ₹4,984 Mn a year ago, a decline of roughly 7%. On a consolidated basis, revenue came in at ₹19,005 Mn (vs ₹20,689 Mn, down ~8%) and consolidated PAT was ₹4,000 Mn (vs ₹4,488 Mn, down ~11%), with EPS of ₹26.37 vs ₹29.59. The agrochemicals segment, which is the main business, saw revenue drop from ₹20,439 Mn to ₹18,287 Mn YoY, while the smaller pharma segment grew sharply from ₹253 Mn to ₹723 Mn but continued to post a pre-tax loss of ₹760 Mn. The statutory auditor Price Waterhouse issued an unmodified limited review conclusion on both sets of results.
Year-on-year revenue and profit have dipped, mainly dragged by weaker agrochemical sales, which may weigh on near-term sentiment. However, the pharma business is scaling up rapidly, the company remains profitable, and the auditor sign-off is clean with no qualifications.